QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2013 | $328,000 | – | 13,795 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |